Navigation Links
Schering-Plough Reports Financial Results for First Quarter of 2008
Date:4/23/2008

RON for hepatitis C increased 4 percent to $225 million in the 2008 first quarter due to higher sales in Latin America, emerging markets across Europe and a favorable impact from foreign exchange, tempered by lower sales in Japan and the United States.

Sales for FOLLISTIM/PUREGON, a fertility treatment, for the first quarter of 2008 were $145 million. Sales for NUVARING, a contraceptive product, in the 2008 first quarter were $96 million. Both products were obtained as part of the OBS acquisition.

Global sales of CLARINEX, a nonsedating antihistamine, in the first quarter of 2008 were $213 million, up 4 percent as compared to sales of $204 million in the first quarter of 2007. Higher sales of CLARINEX in international markets were partially offset by lower sales in the United States.

International sales of prescription CLARITIN were $128 million in the first quarter of 2008, a 14 percent increase compared to sales of $112 million in the first quarter of 2007 as a result of increased sales in Japan due to an early allergy season and favorable foreign exchange.

Sales of the antibiotic AVELOX were up 24 percent to $142 million as a result of increased market share.

Animal Health sales totaled $723 million in the 2008 first quarter. Included in the first quarter of 2008 were net sales of $454 million related to Intervet, the OBS animal health business. Sales benefited from solid growth in all geographic areas, coupled with a positive impact from foreign currency exchange rates.

Consumer Health Care sales were $377 million in the 2008 first quarter, up 9 percent versus the 2007 period. The increase was primarily due to sales of MIRALAX, which was launched in February 2007 as the first Rx-to-OTC switch in the laxative category in more than 30 years, as well as higher sales of OTC CLARITIN, which grew despite the aggressive launch of a competing OTC cetirizine allergy product.

Schering-Plough does not record sales of its cho
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
2. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
3. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
4. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
5. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
6. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
7. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
8. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
11. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 /PRNewswire-iReach/ -- A case ... collaboration between the school,s bioengineering department and the ... the Intel® Software Academic Program, UCSD,s research focuses ... the human body.  Photo - ... exhibits the work of Dr. Todd P. ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
(Date:8/19/2014)... August 20, 2014 One of ... medicine is an inadequate vascular supply. Nutrient and ... decellularized tissues is critical for successful regeneration and ... to mitigate deficiencies in vascularization and promote angiogenesis ... bioactivity, optimizing scaffold design and architecture, and enhancing ...
(Date:8/19/2014)... Research and Markets  has announced the addition of ... Report" report to their offering. This report ... US$ Thousands by the following Product Segments: Media, Sera, and Reagents. ... Canada , Japan , ... Latin America . Annual estimates and forecasts are provided ...
Breaking Biology Technology:Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2EQ-5D™ Assessment Now Available for iPad 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
... ... in the US and Europe, is expanding its services to support ... joins the company as Vice President, Devices & Radiological Health. ... including early design and prototyping, simulation, preclinical and phase I-III clinical ...
... , , , , ... compliance has been called the Achilles heel of modern healthcare. The ... 70% of all medication-related hospital admissions at an estimated annual cost ... cellphone-based drug telemonitoring technology, called eMedonline and developed by Leap ...
... , ATLANTA, Sept. 22 The International Executive ... Associates has joined its global network. IESF is the world,s ... Sanford Rose Associates (SRA) as one of its global partners. ... primarily located throughout the USA will considerably enhance IESF,s presence ...
Cached Biology Technology:Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP 2Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP 3Medication Telemonitoring Improves Compliance and Behavior in NIH Study 2Sanford Rose Associates Joins the International Executive Search Federation 2
(Date:8/19/2014)... the world, leprosy and tuberculosis live side-by-side. Worldwide ... per year, with nearly all of them occurring ... vaccine Bacille Calmette-Guerin, or BCG, provides only partial ... more potent vaccine is needed to combat both ... weapon against both diseases., In a study published ...
(Date:8/19/2014)... a biomarker strongly associated with basal-like breast cancer, ... many types of chemotherapy. The biomarker, a protein ... therapeutics designed to treat this often deadly cancer. ... The Cancer Genome Atlas, molecular biologists Curt M. ... and bioinformatics techniques to detect patterns of gene ...
(Date:8/19/2014)... crocodiles colonised the seas during warm phases and became ... study which establishes a link between marine crocodilian diversity ... of more than 140 million years. , The ... de Lyon, France and formerly from the University of ... Communications ., Today, crocodiles are ,cold-blooded, animals that mainly ...
Breaking Biology News(10 mins):New vaccine shows promise as stronger weapon against both tuberculosis and leprosy 2Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3Evolution of marine crocodilians constrained by ocean temperatures 2
... Robert Sommerlad has thought a lot about the challenges ... mechanical engineering at Newark College of Engineering in 1960. ... of power-plant technologies needed to produce the electricity that ... the recent recipient of one of six NJIT Alumni ...
... MINNEAPOLIS, Oct. 14, 2011 Created to support policies ... thrive, the American Life Sciences Innovation Council (ALSIC) is ... the President and Chief Executive Officer of VIDA Sciences; ... Research at OmniPharm Research International; H. Dean Hart, Chief ...
... women in different ways. In women, symptoms of burgeoning heart disease ... is more lethal than it is in men. Roughly 25 percent ... attack, but among women, 38 percent will die. Women are twice ... 6 years of their first one, and women are twice as ...
Cached Biology News:NJIT alum, power expert, advisor during Exxon/Valdez clean-up, gets award 2NJIT alum, power expert, advisor during Exxon/Valdez clean-up, gets award 3Women's heart disease tied to small blood vessels 2
... Universal Vacuum System UVS400 is a multi-tasking ... UVS400 combines a refrigerated vapor trap and ... single integrated unit. The easy-to-use, wide-mouth glass ... into single jar for easy disposal. The ...
... 2 products into 1:, , A multi-tube ... kit , ,The FastPrep System consists ... System Matrix and Isolation Kits. Samples are ... eliminating the use of metal probes and ...
... is a chromogenic substrate ... plasmids. In the presence ... lac + bacterial ... recombinant colonies appear white. ...
... The LCMS-2010EV is a fully flexible ... including conventional HPLC, high-speed HPLC, 1-D and ... prep scale separations. It incorporates a drying ... mist for high sensitivity, especially for low-to-medium ...
Biology Products: